Isoniazid-Related Hepatic Failure in Children: A Survey of Liver Transplantation Centers

Abstract

While INH-associated liver failure in children is rare, discontinuation at the onset of symptoms does not assure recovery. This indicates a need for increased awareness of hepatotoxicity risk, expanded biochemical monitoring for children receiving INH, and prompt withdrawal in symptomatic patients.